Best Practices for Design and Operation of Multiproduct Manufacturing Facilities Careful design, planning, and record keeping are needed for cleaning and changeover. Feb 02, 2020 By Tim Roach Pharmaceutical Technology Volume 44, Issue 2, pg 35–37 warut - stock.adobe.com Fixed, single-product pharmaceutical factories dedicated to a handful of blockbusters are rapidly becoming a thing of the past. Short timelines, expedited programs, a wide array of increasingly complex therapies, and frequent changeovers between small batches targeting rare diseases place flexible, highly efficient manufacturing plants in high demand. Today’s drug manufacturers—particularly contract development and manufacturing organizations (CDMOs)—must be agile and adaptable. However, operations in modern, multiproduct facilities are complex and must be carefully laid out and orchestrated for optimal results. This article includes some best practices and considerations for the design and operation of multiproduct pharmaceutical manufacturing facilities. Click Here For Complete Article Text
|
|||||||||||||||||||||||||||
| Application Sequencing | |||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
| Company | Product | Process | Other Subjects | Event | Event Date | Location | Publication | Publication Date | Text Descriptor | ||||||||||||||||||
|
|
|
|
|
|
|
|
||||||||||||||||||||